Innovating Works
APTADEGRAD: A novel first in its kind aptamer based LYTACs to address the unmet clinical need of diabetic woun... LINCBIOTECH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Diabetic foot ulcers (DFUs) a major complication of diabetes, occur in ~25% of patients, with a five-year recurrence rate of ~65% . DFUs of...
2022-11-25 - 2027-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.